Gap Discovered in Breast Cancer Radiotherapy Recommendations for Patients Aged 70 vs 69 Years
Age-based heuristics may lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new study published by Talcott et al in the International Journal of Radiation Oncology, Biology, and Physics.Source: The ASCO Post
Five Questions With: Dr. Joseph Renzulli, Dr. Sanjay Aneja and Dr. Matthew Austin
WESTERLY HOSPITAL RECENTLY launched its first multidisciplinary genitourinary oncology clinic, which brings together the expertise of urologic oncology, medical oncology and radiation oncology to treat patients with genitourinary cancers. Pictured from left: Robert Legare, regional medical director of the Smilow Cancer Hospital Care Center at Westerly Hospital; Dr. Matthew Austin, medical oncologist at Westerly Hospital; Rachel Drake, registered nurse; Dr. Sanjay Aneja, radiation oncologist at Westerly Hospital; and Dr. Joseph Renzulli, regional medical director and chief of urology at Westerly Hospital. / COURTESY WESTERLY HOSPITALSource: PBN
Fighting Breast and Ovarian Cancer With a Lupus Antibody
After discovering a specific lupus antibody that can penetrate cancer cells and, with a grant from Women's Health Research at Yale, showing it makes cancer cells vulnerable to standard treatments, Dr. Peter Glazer and his colleagues are moving a treatment to clinical trials.
Throat Cancers Are on the Rise: Why This Matters to You
These cancers are on the rise among men, and HPV is causing the uptick. The Centers for Disease Control and Prevention (CDC) estimates that 79 million Americans are infected with HPV and that 90% of men and 80% of women will be infected with the virus at some point in their lives.Source: Yale Medicine
Humanized Mice Lead to Breakthroughs in Blood Cancers
Humanized mice created at Yale are opening new avenues of research into cancers caused by disorders in the production of blood, such as acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS). Until recently, such research was hindered because human blood stem cells are difficult to grow in cell cultures or to engraft in mice.
Yale Cancer Center study shows Artificial Intelligence can help radiologists find microscopic evidence of advancing head and neck cancer
New findings by researchers at Yale Cancer Center (YCC) show deep learning algorithms can outperforms radiologists in finding microscopic infiltrations of head and neck cancer in lymph nodes.
Yale Cancer Center Researchers Show Adding Radiation After Immunotherapy Improves Survival Time for Patients with Advanced Lung Cancer
The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).
Yale Study Identifies How Cancer Drug Inhibits DNA Repair in Cancer Cells
Yale Cancer Center researchers have found that a cancer drug thought to be of limited use possesses an unforeseen property. It is able to stop certain cancer cells from repairing their DNA in order to survive. The study suggests that combining this drug, cediranib, with other agents could potentially deliver a lethal blow in cancer that uses a specific process to create DNA repair cells.
For Teens Living with Cancer, Keeping Life as 'Normal' as Possible
Yale New Haven Children's Hospital has opened the Lauren Telesz/Smilow Teen Center, to fill an important gap between pediatric and adult cancer care. The center dovetails with a larger goal to help improve survival rates for adolescents and young adults with cancer.Source: Yale Medicine
Yale Study Shows Immunotherapy Drug Helps Patients with Metastatic Melanoma
When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. A study by Yale Cancer Center researchers published today in the Journal of Clinical Oncology (JCO) shows a checkpoint inhibitor immunotherapy drug has meaningful benefit for these patients. The study is one of the first clinical trials aimed at treating the brain metastases with this type of cancer drug.
Knowing the Risks: The Genetics of Breast and Ovarian Cancer
Dr. Ryan Jensen’s work, spurred by a pair of WHRY grants, continues progress toward models uncovering how genetic mutations lead to cancer and helping guide patients and doctors toward decisions that can produce the best health outcomes.
Discovery may help provide clues for fighting and treating HPV
Yale Cancer Center (YCC) scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus (HPV) infects cells. Their findings, published online today in the journal Cell, may eventually help to broaden the scope of defenses against HPV and provide valuable clues for delivering drugs into cells. HPV is a family of killers. Although there are effective vaccines against these viruses, they still cause about 5% of cancer deaths worldwide, including more than 250,000 women who die of cervical cancer each year.
Replacing Conventional Medicine for Complementary Therapy Can Decrease Survival
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER) at Yale School of Medicine. The findings were reported today online in JAMA Oncology.